Evaluating the Effect of Anakinra (r-metHuIL-1ra) on Vaccine AntibodyResponse in Subjects With Rheumatoid Arthritis (RA)

You may be eligible if

• Morning stiffness greater than or equal to 45 minutes;
• C-reactive protein (CRP) greater than or equal to 1.5 mg/dL;
• Erythrocyte sedimentation rate greater than or equal to 28 mm/hr;
• Stable methotrexate dose of less than or equal to 20 mg/week for 8 weeks prior to randomization;